Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Imodium PR to go

This article was originally published in The Tan Sheet

Executive Summary

McNeil's Urban Relief Program to promoteImodium anti-diarrheal offers a "creative bathroom solution for travelers" by temporarily placing 10 artistic port-o-potties at parks throughout Manhattan. Bathrooms were "painted and designed by some of New York's top artists," McNeil says. "Offering relief, comfort and visual enjoyment, the exhibit showcases portable bathrooms that are functional, convenient - and works of art - for a quintessential New York minute"...

You may also be interested in...

Godzillarrhea: McNeil Turns To Giant Lizard In Imodium Ad Campaign

McNeil Consumer & Specialty Pharmaceuticals is using a creature-themed television ad campaign to promote its Imodium AD anti-diarrheal

Health And Wellness Trademark Review 18 February, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Genfit Delays NASH Data While It Confers With US FDA On Methodology

Genfit will delay unblinding of data from its nearly complete Phase III study of elafibranor to get insight from the FDA on statistical methods in order to optimize its NDA.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts